UVEITIS, INTERMEDIATE

Clinical trials for UVEITIS, INTERMEDIATE explained in plain language.

Never miss a new study

Get alerted when new UVEITIS, INTERMEDIATE trials appear

Sign up with your email to follow new studies for UVEITIS, INTERMEDIATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill aims to halt Vision-Threatening eye inflammation

Disease control Ongoing

This study is testing whether an oral medication called brepocitinib is safe and effective for controlling active uveitis, a type of serious eye inflammation that can lead to vision loss. It will involve about 371 adults with intermediate, posterior, or panuveitis. Participants w…

Matched conditions: UVEITIS, INTERMEDIATE

Phase: PHASE3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

UVEITIS, INTERMEDIATE

Get alerted when new UVEITIS, INTERMEDIATE trials appear

New pill aims to halt Vision-Threatening eye inflammation